title: Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.
authors.affiliation: Division of Organ Transplantation, Deaconess Hospital, Boston, MA 02215, USA.
authors.forename: D
authors.initials: D
authors.lastname: Shaffer
authors.forename: P N
authors.initials: PN
authors.lastname: Madras
authors.forename: P
authors.initials: P
authors.lastname: Conway
authors.forename: C
authors.initials: C
authors.lastname: Davis
authors.forename: M A
authors.initials: MA
authors.lastname: Simpson
authors.forename: A P
authors.initials: AP
authors.lastname: Monaco
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000627:therapeutic use; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics / Q000379:methods; D007166:Immunosuppressive Agents / Q000191:economics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D007902:Length of Stay; D019520:Living Donors; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D011183:Postoperative Complications; D013256:Steroids / Q000627:therapeutic use; D015996:Survival Rate
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D009173:Mycophenolic Acid; D001379:Azathioprine